Overview: Sm Antibody IgG TestIntroduction: The Sm Antibody IgG Test detects Sm antibodies to diagnose lupus, causing joint pain or fatigue. Following 2023 ACR guidelines, it uses immunoassays for high specificity, supporting autoimmune screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected systemic lupus erythematosus.
Other Names: Sm Antibody Assay, Anti-Smith IgG Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Sm antibody testing began in the 1960s with lupus research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Sm antibodies to diagnose lupus, guides treatment, and evaluates patients with joint pain or fatigue.
Test Parameters: 1. Sm IgG Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of joint pain, fatigue, or autoimmune symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document joint pain, fatigue, or family history of lupus. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, lupus implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect Sm IgG antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for lupus diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Cross-reactivity with other autoantibodies may reduce specificity.
Clinical Significance: Positive Sm antibodies confirm lupus, guiding immunosuppressive therapy. Negative results may require ANA or dsDNA testing.
Specialist Consultation: Consult a rheumatologist for result interpretation and treatment planning.
Additional Supporting Tests: ANA, anti-dsDNA, or complement levels to confirm lupus diagnosis.
Test Limitations: Non-specific for certain autoimmune conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: ACR Lupus Guidelines, 2023; Arthritis & Rheumatology, Tsokos GC, 2022.
